GAPDH (D16H11) Rabbit Monoclonal Antibody (HRP Conjugate) and 3 more items

Cell Signaling Technology Inc. has been awarded contract A207_PO-0485641 by the University of Virginia, effective September 29, 2026. The cumulative contract value totals $1,213.60. Based on the awardee's core business operations, this contract likely involves the provision of research reagents, antibodies, or cell signaling pathway analysis products commonly supplied to academic and research institutions. The specific scope of work, performance location, and detailed line items are not disclosed in the available contract documentation.

The University of Virginia, located in Virginia, serves as the contracting organization and implied place of performance. While the contract's annual value and total contract amount are not specified in the award notice, the cumulative value of $1,213.60 suggests this represents either a purchase order for limited quantities of materials or a task order under an existing indefinite-delivery contract. The period of performance and any renewal options are not detailed in the source materials provided.